Allogeneic Hematopoietic Cell Transplantation and Other Expensive Cellular Therapies: A Miracle for the Few but Off Limits to Many?

Author:

Khera Nandita1,Deeg H. Joachim2,Kodish Eric3,Rondelli Damiano4,Majhail Navneet3

Affiliation:

1. Mayo Clinic, Phoenix, AZ

2. Fred Hutchinson Cancer Research Center, Seattle, WA

3. Cleveland Clinic, Cleveland, OH

4. University of Illinois at Chicago, Chicago, IL

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Reference50 articles.

1. One million haemopoietic stem-cell transplants: a retrospective observational study

2. Center for International Blood & Marrow Transplant Research (CIBMTR): Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT) 2018 Summary Slides. https://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/_layouts/15/WopiFrame.aspx?sourcedoc=/ReferenceCenter/SlidesReports/SummarySlides/Documents/2018%20Summary%20Slides%20-%20final%20-%20for%20web%20posting.pptx&action=default

3. Prevalence of Hematopoietic Cell Transplant Survivors in the United States

4. HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry

5. Estimating Demand and Unmet Need for Allogeneic Hematopoietic Cell Transplantation in the United States Using Geographic Information Systems

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3